Brook Byers

Brook Byers is a founding member of Kleiner Perkins. A venture capital investor since 1972, Brook has been closely involved with more than 80 new technology-based ventures, many of which have become public companies. He formed the first life sciences practice group in the venture capital profession in 1984 and led KP to become a premier venture capital firm in the medical, healthcare and biotechnology sectors. KP has invested in and helped build more than 120 life sciences companies that have developed hundreds of products to treat underserved medical needs for many millions of patients. Brook has been an innovator in precision medicine and health genomics, antibodies, devices, diagnostics, and cell therapy. He was the founding president and then chairman of four biotechnology companies that were incubated in KP’s offices and went on to become public companies with an aggregate market value of more than US $8 billion. He serves on the board of directors of Arsenal, Enjoy, Newsela, Octave and Verana Health.

Brook serves on the Board of Overseers of the University of California San Francisco medical campus and hospitals, the Stanford Medicine Advisory Council, the Board of Directors of the New Schools Foundation, the Advisory Board of Stanford’s Center for Precision Health and Integrated Diagnostics and the Stanford Center for Biodesign. In 2007, UCSF awarded Brook the UCSF Medal, its honorary degree equivalent. In 2008, Brook was elected a fellow of the American Academy of Arts and Sciences. In 2009, he received the Lifetime Achievement Award from the National Venture Capital Association. In 2010, he received an honorary Ph.D. from Georgia Institute of Technology.

Raised in Atlanta, Georgia, Brook graduated with a bachelor’s degree in electrical engineering from Georgia Tech and received an M.B.A. from Stanford University.